Literature DB >> 17701101

Chorioretinal anastomosis after photodynamic therapy for polypoidal choroidal vasculopathy: CRA after PDT for PCV.

Yuko Yodoi1, Akitaka Tsujikawa, Atsushi Otani, Hiroko Aikawa, Nagahisa Yoshimura.   

Abstract

An 80-year-old woman was treated with photodynamic therapy (PDT) to the left eye for polypoidal choroidal vasculopathy (PCV). About 3 months after PDT, her left eye developed a chorioretinal anastomosis with severe atrophy of the retinal pigment epithelium in the macula; visual acuity in this eye was 20/1000. She received a second session of PDT, plus an intravitreal injection of triamcinolone acetonide. About 3 months after the second treatment, the chorioretinal anastomosis was enlarged and the retinal vessels involved in the anastomosis were more dilated. About 1 year after the first PDT, visual acuity in the left eye had stabilized at 20/400. Development of a chorioretinal anastomosis is a distinct possibility following PDT in eyes with PCV, and can lead to poor visual recovery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17701101     DOI: 10.1007/s10792-007-9129-7

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  7 in total

1.  Choroidal infarction following photodynamic therapy with verteporfin.

Authors:  Christina M Klais; Michael D Ober; K Bailey Freund; Leonard H Ginsburg; Alan Luckie; Martine Mauget-Faÿsse; Gabriel Coscas; Nicole E Gross; Lawrence A Yannuzzi
Journal:  Arch Ophthalmol       Date:  2005-08

2.  The posterior uveal bleeding syndrome.

Authors:  R C Kleiner; A J Brucker; R L Johnston
Journal:  Retina       Date:  1990       Impact factor: 4.256

3.  Idiopathic polypoidal choroidal vasculopathy (IPCV).

Authors:  L A Yannuzzi; J Sorenson; R F Spaide; B Lipson
Journal:  Retina       Date:  1990       Impact factor: 4.256

4.  [Chorioretinal anastomosis as unfavourable prognostic factor during photodynamic therapy].

Authors:  C Kusserow; S Michels; U Schmidt-Erfurth
Journal:  Ophthalmologe       Date:  2003-03       Impact factor: 1.059

5.  Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.

Authors:  Wai-Man Chan; Dennis S C Lam; Timothy Y Y Lai; David T L Liu; Kenneth K W Li; Yi Yao; Tak-Hung Wong
Journal:  Ophthalmology       Date:  2004-08       Impact factor: 12.079

6.  Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy.

Authors:  Yasuhiko Hirami; Akitaka Tsujikawa; Atsushi Otani; Yuko Yodoi; Hiroko Aikawa; Michiko Mandai; Nagahisa Yoshimura
Journal:  Retina       Date:  2007-03       Impact factor: 4.256

7.  Choroidal vein and artery occlusion following photodynamic therapy in eyes with pathologic myopia.

Authors:  Kyoko Ohno-Matsui; Muka Moriyama; Kengo Hayashi; Manabu Mochizuki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-08       Impact factor: 3.117

  7 in total
  1 in total

1.  Factors influencing visual outcome of polypoidal choroidal vasculopathy one year after photodynamic therapy.

Authors:  Ryusaburo Mori; Mitsuko Yuzawa; Zeon Lee; Miho Haruyama; Eriko Akaza
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-30       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.